Listing 1 - 5 of 5 |
Sort by
|
Choose an application
Biology. --- Stem cells --- COVID-19 (Disease) --- Cytokines. --- COVID-19 --- Cytokine Release Syndrome --- Stem Cells --- Therapeutic use. --- Treatment. --- COVID-19. --- Cytokine Release Syndrome. --- Stem Cells.
Choose an application
Cytokine Storm Syndromes, including HLH and MAS, are frequently fatal disorders, particularly if not recognized early and treated during presentation. The genetics of Cytokine Storm Syndromes are being defined with many of the risk alleles giving rise to mutations in the perforin-mediated cytolytic pathway used by CD8 cytotoxic T cells and natural killer cells. These are being studied using murine models. Up to 10% of the general population may carry risk alleles for developing Cytokine Storm Syndromes, and Cytokine Storm Syndromes are being increasingly recognized around the world in pediatric and adult hospitals. A variety of infectious, rheumatic, and oncologic triggers are commonly associated with Cytokine Storm Syndromes, but understanding this disorder is critical for all researchers and physicians to ensure timely and appropriate therapy. This second edition addresses all aspects of the disorder, from genetics, pathophysiology, and ongoing research, to clinical presentations, risk factors and treatment. New-to-this-edition features include dedicated chapters on severe COVID-19 CSS, and post-COVID CSS of multi-system inflammatory syndrome in children (MIS-C). In addition, novel topics including CSS associated with Castleman disease, pregnancy, therapeutics, transplantation, and cardiac bypass, as well as treatment with JAK inhibitors are addressed. .
Cytokines. --- Immunologic diseases. --- Cytokine Release Syndrome. --- Immune System Diseases. --- Macrophage Activation Syndrome. --- Lymphohistiocytosis, Hemophagocytic --- Immunology. --- Molecular genetics. --- Diseases. --- Molecular Genetics. --- Cytokines and Growth Factors.
Choose an application
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures).
Medicine --- Environmental medicine --- COVID-19 --- SARS-CoV-2 --- hepatitis B and C --- cirrhosis --- chronic kidney disease --- alcohol-related liver disease --- nonalcoholic steatohepatitis --- necrosis --- MDR-TB --- clinical trials --- IL-6 inhibitors --- tocilizumab --- cytokine release syndrome --- cytokine storm --- operational research --- health systems --- SORT IT --- pandemics --- training --- pandemic --- endemic --- tuberculosis --- impact --- control --- overview --- malaria --- preparedness --- Africa --- emergency --- fecal calprotectin --- bowel perforation --- D-Dimer --- thrombosis --- ischemia --- efficacy --- safety --- kaletra --- lopinavir/ritonavir --- meta-analysis --- coronavirus --- SARS-CoV-1 --- MERS --- SARS --- influenza --- healthcare worker --- healthcare personnel --- general practitioners --- medical doctor --- heart transplant --- CMV --- Chagas disease --- infection --- severity --- respiratory viruses --- coinfections --- health care workers --- Philippines --- rhinovirus --- severe acute respiratory syndrome coronavirus 2 --- plasmodium falciparum --- differential diagnosis --- cognitive bias --- diagnostic reasoning --- recurrence --- reinfection --- Bangladesh --- Kenya --- Nairobi --- presumptive tuberculosis --- TB treatment outcomes --- HIV --- antiretroviral therapy --- EpiCollect5 --- Malawi --- Lilongwe --- Zimbabwe --- Harare --- real-time operational research --- ethics --- research capacity building --- India --- Nepal --- post-acute COVID-19 syndrome --- COVID-19 vaccines --- mortality --- epidemiology --- public health --- healthcare workers --- attitudes --- perceptions --- knowledge --- n/a
Choose an application
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures).
COVID-19 --- SARS-CoV-2 --- hepatitis B and C --- cirrhosis --- chronic kidney disease --- alcohol-related liver disease --- nonalcoholic steatohepatitis --- necrosis --- MDR-TB --- clinical trials --- IL-6 inhibitors --- tocilizumab --- cytokine release syndrome --- cytokine storm --- operational research --- health systems --- SORT IT --- pandemics --- training --- pandemic --- endemic --- tuberculosis --- impact --- control --- overview --- malaria --- preparedness --- Africa --- emergency --- fecal calprotectin --- bowel perforation --- D-Dimer --- thrombosis --- ischemia --- efficacy --- safety --- kaletra --- lopinavir/ritonavir --- meta-analysis --- coronavirus --- SARS-CoV-1 --- MERS --- SARS --- influenza --- healthcare worker --- healthcare personnel --- general practitioners --- medical doctor --- heart transplant --- CMV --- Chagas disease --- infection --- severity --- respiratory viruses --- coinfections --- health care workers --- Philippines --- rhinovirus --- severe acute respiratory syndrome coronavirus 2 --- plasmodium falciparum --- differential diagnosis --- cognitive bias --- diagnostic reasoning --- recurrence --- reinfection --- Bangladesh --- Kenya --- Nairobi --- presumptive tuberculosis --- TB treatment outcomes --- HIV --- antiretroviral therapy --- EpiCollect5 --- Malawi --- Lilongwe --- Zimbabwe --- Harare --- real-time operational research --- ethics --- research capacity building --- India --- Nepal --- post-acute COVID-19 syndrome --- COVID-19 vaccines --- mortality --- epidemiology --- public health --- healthcare workers --- attitudes --- perceptions --- knowledge --- n/a
Choose an application
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 presents significant challenges to health systems and public health in both hemispheres as well as to the economies of each country. The morbidity and mortality due to infections caused by SARS-CoV-2 have been significant despite the short duration since its discovery and initially overwhelmed many hospitals and clinics. It influences everyone, and countermeasures have been dramatic in their impact on employment, social systems, and mental health. This Special Issue provides an avenue for authors from various disciplines to provide feedback on our responses and preparedness to COVID-19 globally as well as to disseminate critical information about the SARS-CoV-2 virus and the associated COVID-19 pandemic. It consists of 22 peer-reviewed papers that cover worldwide perspectives encompasses the following: Original articles about COVID-19 (including epidemiology, modelling, clinical data, treatment, prevention, countermeasures, impacts on tropical regions, response, and preparedness);Original articles about SARS-CoV-2 (microbiology, virology, transmission, pathology, and vaccinology);Perspectives about COVID-19 and SARS-CoV-2 (comparisons with past coronavirus outbreaks, impactful local initiatives, novel responses, and commentaries);Reviews on COVID-19 (based on systematic and narrative reviews);and Innovations (vaccine development, drug trials, and original countermeasures).
Medicine --- Environmental medicine --- COVID-19 --- SARS-CoV-2 --- hepatitis B and C --- cirrhosis --- chronic kidney disease --- alcohol-related liver disease --- nonalcoholic steatohepatitis --- necrosis --- MDR-TB --- clinical trials --- IL-6 inhibitors --- tocilizumab --- cytokine release syndrome --- cytokine storm --- operational research --- health systems --- SORT IT --- pandemics --- training --- pandemic --- endemic --- tuberculosis --- impact --- control --- overview --- malaria --- preparedness --- Africa --- emergency --- fecal calprotectin --- bowel perforation --- D-Dimer --- thrombosis --- ischemia --- efficacy --- safety --- kaletra --- lopinavir/ritonavir --- meta-analysis --- coronavirus --- SARS-CoV-1 --- MERS --- SARS --- influenza --- healthcare worker --- healthcare personnel --- general practitioners --- medical doctor --- heart transplant --- CMV --- Chagas disease --- infection --- severity --- respiratory viruses --- coinfections --- health care workers --- Philippines --- rhinovirus --- severe acute respiratory syndrome coronavirus 2 --- plasmodium falciparum --- differential diagnosis --- cognitive bias --- diagnostic reasoning --- recurrence --- reinfection --- Bangladesh --- Kenya --- Nairobi --- presumptive tuberculosis --- TB treatment outcomes --- HIV --- antiretroviral therapy --- EpiCollect5 --- Malawi --- Lilongwe --- Zimbabwe --- Harare --- real-time operational research --- ethics --- research capacity building --- India --- Nepal --- post-acute COVID-19 syndrome --- COVID-19 vaccines --- mortality --- epidemiology --- public health --- healthcare workers --- attitudes --- perceptions --- knowledge
Listing 1 - 5 of 5 |
Sort by
|